Relevant bibliographies by topics / Treatment responder

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Treatment responder'

Author: Grafiati
Published: 3 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Treatment responder.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Treatment responder"

1

Lee, Seo-Ho, Dennis M. Bonal, Diana Olguta Treaba, et al. "Sry-Box Transcription Factor 9 (SOX9)-Driven Mesenchymal Stromal Cell Differentiation Signature As a Determinant of Induction Chemotherapy Responsiveness in Acute Myeloid Leukemia Core Bone Marrow Biopsies." Blood 142, Supplement 1 (2023): 4299. http://dx.doi.org/10.1182/blood-2023-189679.

Full text
Abstract:
Leukemic clones in acute myeloid leukemia (AML) alter the bone marrow (BM) microenvironment so that the normal functions of hematopoietic stem cells (HSCs) are interrupted, aiding malignant progression. Accumulating evidence points to a protective role that the microenvironment provides for the AML clone (Colmone et al., Science, 2008). It is therefore crucial to detail the mechanisms by which the BM stroma promotes leukemia progression to inform the development of more effective targeted therapies. Most studies focused on detailing the role of BM stroma in AML etiology use BM aspirates, which
APA, Harvard, Vancouver, ISO, and other styles
2

Barrow, Rhiannon, James A. Poulter, Martina A. Finetti, Erica Wilson, Colin A. Johnson, and Lucy Stead. "Modulation of GABA Neurotransmitter Signalling Impacts Glioblastoma Spheroid Growth and Response to Standard Treatment." Neuro-Oncology 24, Supplement_4 (2022): iv3—iv4. http://dx.doi.org/10.1093/neuonc/noac200.013.

Full text
Abstract:
Abstract AIMS We have identified two subtypes within glioblastoma (GBM), defined by whether a specific subset of genes is upregulated (Up responders) or downregulated (Down responders) in response the standard treatment. The biology of therapy-driven transcriptional reprogramming in the two subtypes suggests the differential involvement of GABA neurotransmitter signalling in the underlying treatment resistance mechanisms. Our aim was to address our hypothesis that modulating GABA signalling will impact treatment response in GBM, in different ways for different responder subtypes. METHOD We ide
APA, Harvard, Vancouver, ISO, and other styles
3

Vancappel, Alexis, Yecodji Dansou, Ophelia Godin, et al. "Evolution of Cognitive Impairments in Treatment-Resistant Depression: Results from the Longitudinal French Centers of Expertise for Treatment-Resistant Depression (FACE-DR) Cohort." Brain Sciences 13, no. 7 (2023): 1120. http://dx.doi.org/10.3390/brainsci13071120.

Full text
Abstract:
Previous studies set out profound cognitive impairments in subjects with treatment-resistant depression (TRD). However, little is known about the course of such alterations depending on levels of improvement in those patients followed longitudinally. The main objective of this study was to describe the course of cognitive impairments in responder versus non-responder TRD patients at one-year follow-up. The second aim was to evaluate the predictive aspect of cognitive impairments to treatment resistance in patients suffering from TRD. We included 131 patients from a longitudinal cohort (FACE-DR
APA, Harvard, Vancouver, ISO, and other styles
4

Treaba, Diana O., Dennis M. Bonal, Anna D. Chorzalska, et al. "Levels of Osteopontin (SPP1), Osteonectin (SPARC) and Biglycan (BGN) in Acute Myeloid Leukemia Bone Marrow Biopsies Post-Induction Therapy Define the Status of Osteogenic Niche and Show Inverse Correlation with Therapeutic Response." Blood 136, Supplement 1 (2020): 29–30. http://dx.doi.org/10.1182/blood-2020-142604.

Full text
Abstract:
Background: Acute Myeloid Leukemia (AML) has a five-year survival rate of 25% and its high mortality is linked to poor response to treatment and relapse. Our understanding of the molecular mechanisms controlling relapse and AML progression is limited. Animal models indicate that AML cells significantly modulate their bone marrow microenvironment inducing gradual loss of endosteal and vascular niches, both playing critical roles in support and maintenance of normal hematopoiesis. The goal of this study was to determine microenvironmental factors driving the gradual retraction of endosteal and v
APA, Harvard, Vancouver, ISO, and other styles
5

Schreiber, S. W., D. B. Clemow, A. Keohane, et al. "P1071 Trajectories of response in patients with moderately-to-severely active ulcerative colitis treated with mirikizumab: Results from the LUCENT-1 study." Journal of Crohn's and Colitis 19, Supplement_1 (2025): i1978—i1979. https://doi.org/10.1093/ecco-jcc/jjae190.1245.

Full text
Abstract:
Abstract Background Mirikizumab, an anti-IL-23p19 antibody, demonstrated robust efficacy in improving clinical and endoscopic endpoints with an acceptable safety profile1. We explored the trajectory of response to mirikizumab treatment in patients with moderate-to-severely active ulcerative colitis. Methods Mirikizumab patients described previously1 were assessed via Growth Mixture Model (GMM) to identify distinct clusters based on individual patient response trajectories. The sum of stool frequency and rectal bleeding modified Mayo subscores was used in the GMM to identify trajectories. Week
APA, Harvard, Vancouver, ISO, and other styles
6

Editorial Staff. "Genetic Polymorphisms in GABRD and Treatment Response and Dose in Methadone Maintenance Treatment." Precision Medicine Communications 1, no. 1 (2021): 05–07. http://dx.doi.org/10.55627/pmc.001.01.0073.

Full text
Abstract:
Xie and colleagues studied the association between the genetic polymorphs of the GABA receptor delta subunit (GABARD) and dose-response to methadone in heroin addicts subjected to methadone maintenance therapy (MMT) was studied. They investigated two groups: responders and non-responders were created from a total of 286 recruited MMT patients where the parameter for classification was retention time in therapy. According to stabilized methadone dose, 177 patients were divided into subgroups of high dose and low dose. TaqMan SNP assay was used for GABRD genotyping and the following single nucle
APA, Harvard, Vancouver, ISO, and other styles
7

Sudo, Kazuki, Ken Kato, Juntaro Matsuzaki, et al. "Serum microRNAs to predict the response to nivolumab in patients with esophageal squamous cell carcinoma." Journal of Clinical Oncology 35, no. 15_suppl (2017): e14511-e14511. http://dx.doi.org/10.1200/jco.2017.35.15_suppl.e14511.

Full text
Abstract:
e14511 Background: A phase II study demonstrated that nivolumab (Nivo), a PD-1 inhibitor, had a meaningful activity for patients with esophageal squamous cell carcinoma. Although several biomarkers, including PD-L1 expression levels in tumor tissue, are explored to predict the efficacy of Nivo, further investigation is needed. Here we evaluated whether serum levels of microRNA (miRNA) could be a candidate of predictive markers. Methods: Among 65 patients who participated in the phase II study (JapicCTINo.142422) and received Nivo 3 mg/kg IV Q2W, 19 patients were treated at our institution. Pat
APA, Harvard, Vancouver, ISO, and other styles
8

Sánchez-Sanz, Alicia, Rafael Muñoz-Viana, Julia Sabín-Muñoz, et al. "Response to Fingolimod in Multiple Sclerosis Patients Is Associated with a Differential Transcriptomic Regulation." International Journal of Molecular Sciences 25, no. 3 (2024): 1372. http://dx.doi.org/10.3390/ijms25031372.

Full text
Abstract:
Fingolimod is an immunomodulatory sphingosine-1-phosphate (S1P) analogue approved for the treatment of relapsing-remitting multiple sclerosis (RRMS). The identification of biomarkers of clinical responses to fingolimod is a major necessity in MS to identify optimal responders and avoid the risk of disease progression in non-responders. With this aim, we used RNA sequencing to study the transcriptomic changes induced by fingolimod in peripheral blood mononuclear cells of MS-treated patients and their association with clinical response. Samples were obtained from 10 RRMS patients (five responder
APA, Harvard, Vancouver, ISO, and other styles
9

M Arif, Rana, Fahad Aman Khan, Imran Khan, Muzammil Aslam Kataria, Jawed Iqbal, and Mukhtar Ahmed. "Vitamin D Deficiency in HCV Antiviral Treatment Responders versus Non-Responders." Journal of Islamabad Medical & Dental College 8, no. 1 (2019): 45–49. http://dx.doi.org/10.35787/jimdc.v8i1.316.

Full text
Abstract:
Background: Hepatitis C virus (HCV) is a major cause of chronic liver disease (CLD). Pakistan has a high burden of infectious diseases, including HCV. Its prevalence varies according to geographic regions in the country from about 2·4% to 6·5%. The objective of the study was to compare the frequency of vitamin D deficiency in responders and non-responders of antiviral treatment for chronic hepatitis C.Material and Methods: This comparative cross-sectional study was conducted in Hepatitis Clinic, Jinnah hospital, Lahore from 20th May to 20th November 2013. After ethical approval, participants w
APA, Harvard, Vancouver, ISO, and other styles
10

Van Hoef, M. "Interim results of a survey to evaluate use and interest in autologous and allogeneic bone marrow transplant as a treatment option among patients." Journal of Clinical Oncology 27, no. 15_suppl (2009): e17569-e17569. http://dx.doi.org/10.1200/jco.2009.27.15_suppl.e17569.

Full text
Abstract:
e17569 Background: A survey was placed on websites inviting patients to provide an opinion about bone marrow transplant as treatment option for their disease. Herein an interim analysis of results is presented. Methods: A survey was developed requesting general information about the responder, the disease, and the experience with and interest in autologous and allogeneic donor transplants as treatment option for disease. The survey was placed on sites in the Netherlands and Belgium (cancer fora and website) and was initially announced in a few magazins. Results: Several cancer fora in the Neth
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Treatment responder"

1

Gloster, Andrew T., Rainer Sonntag, Jürgen Hoyer, et al. "Treating Treatment-Resistant Patients with Panic Disorder and Agoraphobia Using Psychotherapy: A Randomized Controlled Switching Trial." Karger, 2015. https://tud.qucosa.de/id/qucosa%3A71640.

Full text
Abstract:
Background: Nonresponsiveness to therapy is generally acknowledged, but only a few studies have tested switching to psychotherapy. This study is one of the first to examine the malleability of treatment-resistant patients using acceptance and commitment therapy (ACT). Methods: This was a randomized controlled trial that included 43 patients diagnosed with primary panic disorder and/or agoraphobia (PD/A) with prior unsuccessful state-of-the-art treatment (mean number of previous sessions = 42.2). Patients were treated with an ACT manual administered by novice therapists and followed up for 6 mo
APA, Harvard, Vancouver, ISO, and other styles
2

Byström, Per. "Colorectal cancer treatment and early response evaluation how do we best evaluate treatment response? /." Stockholm, 2010. http://diss.kib.ki.se/2010/978-91-7409-766-5/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Clowes, Jackie A. "The effect of dietary factors and osteoporosis treatment on bone turnover." Thesis, University of Sheffield, 2002. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.251195.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Singh, Namrata. "The Effects of Parent Training in Pivotal Response Treatment (PRT) and Continued Support through Telemedicine on Gains in Communication in Children with Autism Spectrum Disorder." Thesis, The University of Arizona, 2014. http://hdl.handle.net/10150/315907.

Full text
Abstract:
A Thesis submitted to The University of Arizona College of Medicine - Phoenix in partial fulfillment of the requirements for the Degree of Doctor of Medicine.<br>Introduction: With the increase in children diagnosed with autism spectrum disorders (ASD) each year comes the need for individualized interventions necessary for children with autism. Many of the treatments currently available are time consuming, costly, and rely heavily on behavioral interventionists despite the lack of qualified interventionists to provide these services. Therefore, there is a growing recognition of the need for ef
APA, Harvard, Vancouver, ISO, and other styles
5

Philip, Judith Mary Dundas. "Immune responses following Praziquantel treatment of schistosomiasis." Thesis, University of Cambridge, 2005. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.615292.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Matthiasson, Páll. "Dealing with treatment resistance to clozapine : characteristics of treatment response in schizophrenia." Thesis, King's College London (University of London), 2006. https://kclpure.kcl.ac.uk/portal/en/theses/dealing-with-treatment-resistance-to-clozapine--characteristics-of-treatment-response-in-schizophrenia(f43c968b-8789-44e7-9161-3cab811ee429).html.

Full text
Abstract:
Background: Clozapine, the treatment of choice in treatment-resistant schizophrenia, is not effective in up to half of patients. Aims of this thesis were: to verify whether clozapine augmentation with amisulpride, an atypical antipsychotic with preferential affinity at doparninergic D2-like receptors, is clinically effective; to test the prediction that changes in D2-like receptor availability might explain that improvement; to explore clinical and receptor availability characteristics of good clozapine responders. Methods: Study 1: Thirty-three patients with schizophrenia, partially or non-re
APA, Harvard, Vancouver, ISO, and other styles
7

Sunkara, Sesh. "Interventions for poor responders undergoing in vitro fertilisation treatment." Thesis, King's College London (University of London), 2013. https://kclpure.kcl.ac.uk/portal/en/theses/interventions-for-poor-responders-undergoing-in-vitro-fertilisation-treatment(63a0ad08-f73f-406e-93db-7aa226d4c160).html.

Full text
Abstract:
This thesis examines the various interventions proposed for the management of poor responders undergoing IVF treatment. I began by performing a systematic review and meta-analysis to identify the ideal controlled ovarian hyperstimulation (COH) regimen for women with poor ovarian response undergoing IVF. The systematic review found the evidence to be inconsistent and inconclusive. The poor responders intervention trial (PRINT) was thus conceived. PRINT is an RCT comparing the gonadotrophin releasing hormone (GnRH) agonist long versus the GnRH agonist short versus the GnRH antagonist regimens fo
APA, Harvard, Vancouver, ISO, and other styles
8

Weverling, Gerrit Jan. "Measuring treatment response in HIV-1 infection." [S.l. : Amsterdam : s.n.] ; Universiteit van Amsterdam [Host], 2000. http://dare.uva.nl/document/83204.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Quinn, Stephen. "Uterine fibroids : response to novel treatment modalities." Thesis, Imperial College London, 2013. http://hdl.handle.net/10044/1/24737.

Full text
Abstract:
Magnetic resonance-guided focused ultrasound (MRgFUS) is a non-invasive, thermal ablation treatment for uterine fibroids. There is currently limited data regarding the long-term efficacy of this method and the effect of this treatment on circulating cytokine and growth factors. In this thesis I have: 1. Presented the most accurate method of measuring fibroid volumes, and propose a new classification system for describing fibroid uteri. 2. Reviewed the characteristics of a cohort of uterine fibroid subjects and perform a longitudinal analysis of MRgFUS results. 3. Assessed the fibroid volume tr
APA, Harvard, Vancouver, ISO, and other styles
10

Ghadiri, Mahtab. "Peripheral Immune Phenotyping in Multiple Sclerosis: Immunomodulatory Treatment Effects and Treatment Response Biomarkers." Thesis, The University of Sydney, 2019. http://hdl.handle.net/2123/20809.

Full text
Abstract:
Disease modifying therapies (DMTs) used in the treatment of relapsing remitting multiple sclerosis (RRMS) have broad effects on the immune system that are incompletely understood. There is great heterogeneity in treatment response to most DMTs. However, biomarkers predicting treatment response are lacking. In this thesis, the peripheral immune changes induced by treatment with two DMTs, fingolimod (FTY) and dimethyl fumarate (DMF), are examined in detail by immune phenotyping using multicolour flow cytometry. Chapter 3 presents a longitudinal study of T cell subsets in patients commencing tr
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Treatment responder"

1

Aehlert, Barbara. Emergency medical responder: First responder in action. 2nd ed. McGraw Hill, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

S, Mitchell Malcolm, ed. Biological approaches to cancer treatment: Biomodulation. McGraw-Hill, Health Professions Division, 1993.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

1947, Talpaz Moshe, Kurzrock Razelle, and Gutterman Jordan U, eds. Biological response modifiers in the treatment of hematopoietic neoplasia. Dekker, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

College, Cornell University Medical, and United States. Army Medical Research and Development Command, eds. Immunologic intervention in HIV infection: Anti-polymerase responses and hormonal regulation. U.S. Army Medical Research and Development Command, 1992.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Pfeifer, Patrice. Doctor, ¿es la próstata?: Un urólogo responde sin rodeos a todas sus preguntas. Hispano Europea, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Pescatore, Fred. The science of AHCC: Supplement for 21st century cancer treatment. Basic Health Publications, 2010.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Jainchill, Nancy. Understanding and treating adolescent substance use disorders: Assessment, treatment, juvenile justice responses. Civic Research Institute, 2012.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Yau, Kenneth Kwok Chi. Assessing and predicting treatment responses to cholinesterase inhibitor pharmacotherapy in Alzheimer's disease. National Library of Canada, 2000.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

Division, United States Environmental Protection Agency Emissions Standards. Sewage treatment plant NSPS: Responses to comments on April 1986 proposed revisions. U.S. Environmental Protection Agency, Office of Air and Radiation, Office of Air Quality Planning and Standards, 1988.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

International Conference on Chemical Modifiers of Cancer Treatment (9th 1995 Oxford, Great Britain). Ninth International Conference on Chemical Modifiers of Cancer Treatment: Oxford, UK, 22-26 August 1995. Stockton Press, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Treatment responder"

1

Gralnik, Leonard M., and Jose A. Rey. "Psychopharmacologic Treatment of Psychiatric Disorders in First Responders." In First Responder Mental Health. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-38149-2_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Miller, Laurence. "Psychological Stress Syndromes and Treatment Strategies for Law Enforcement Personnel." In First Responder Mental Health. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-38149-2_1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Habr-Gama, Angelita, Maria Susana Bruzzi, Maria Laura Morici, Guilherme Pagin São Julião, and Rodrigo Oliva Perez. "The Proper Treatment for the Complete Responder After Neoadjuvant Therapy." In Surgical Techniques in Rectal Cancer. Springer Japan, 2017. http://dx.doi.org/10.1007/978-4-431-55579-7_5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Weissman, Ariel, and Colin M. Howles. "Treatment Strategies in Assisted Reproduction for the Poor-Responder Patient." In Textbook of Assisted Reproductive Techniques, 6th ed. CRC Press, 2023. http://dx.doi.org/10.1201/9781003268611-52.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Beidel, Deborah C., Kathryn D. Sunderman, Ashley T. Winch, and Clint A. Bowers. "Virtual Reality Treatments." In First Responder Mental Health. Springer International Publishing, 2023. http://dx.doi.org/10.1007/978-3-031-38149-2_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Turiault, Marc, Caroline Cohen, Guy Griebel, et al. "Treatment Response." In Encyclopedia of Psychopharmacology. Springer Berlin Heidelberg, 2010. http://dx.doi.org/10.1007/978-3-540-68706-1_1423.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Kalelioglu, Tuba, and Sohil H. Patel. "Treatment Response." In Hybrid PET/MR Neuroimaging. Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-82367-2_50.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Nover, L. "Hyperthermic Treatment of Cancer." In Heat Shock Response. CRC Press, 2022. http://dx.doi.org/10.1201/9780367811730-25.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Lautenschlaeger, Tim, Martha Matuszak, and Feng-Ming (Spring) Kong. "Treatment response assessment and response guided adaptive treatment." In Principles and Practice of Image-Guided Radiation Therapy of Lung Cancer. CRC Press, 2017. http://dx.doi.org/10.1201/9781315143873-16.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Koegel, Lynn Kern, Kristen Ashbaugh, and Robert L. Koegel. "Pivotal Response Treatment." In Evidence-Based Practices in Behavioral Health. Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-30925-5_4.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Treatment responder"

1

Furrer, Coline, Trisha I. Valerio, Sophia-Joy X. Patrock, et al. "Nano-ablative immunotherapy for the treatment of pancreatic cancer." In Biophotonics and Immune Responses XX, edited by Wei R. Chen and Feifan Zhou. SPIE, 2025. https://doi.org/10.1117/12.3043426.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Valerio, Trisha I., Coline Furrer, Jacob Adams, et al. "Optimization of localized ablative immunotherapy for pancreatic cancer treatment." In Biophotonics and Immune Responses XX, edited by Wei R. Chen and Feifan Zhou. SPIE, 2025. https://doi.org/10.1117/12.3044084.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Gric, Tatjana, and Edik U. Rafailov. "Metamaterial formalism approach towards precise choice of the antibiotic treatment." In Biophotonics and Immune Responses XX, edited by Wei R. Chen and Feifan Zhou. SPIE, 2025. https://doi.org/10.1117/12.3039807.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Saad, Mohammad A., Derek Allen, Nayab Tahir, et al. "Enhancing immune responses in pre-clinical oral cancer models through photodynamic priming using a low-cost imaging and treatment device." In Biophotonics and Immune Responses XX, edited by Wei R. Chen and Feifan Zhou. SPIE, 2025. https://doi.org/10.1117/12.3044068.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Roth, Michael D., Chi-Hong Tseng, Philip J. Clements, et al. "Predicting Treatment Outcomes And Responder Subsets In Scleroderma-Related Interstitial Lung Disease." In American Thoracic Society 2011 International Conference, May 13-18, 2011 • Denver Colorado. American Thoracic Society, 2011. http://dx.doi.org/10.1164/ajrccm-conference.2011.183.1_meetingabstracts.a3822.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Vervoort, V., J. Vriezekolk, and C. van den Ende. "OP0344-HPR Development of responder criteria for multicomponent non-pharmacological treatment in fibromyalgia." In Annual European Congress of Rheumatology, 14–17 June, 2017. BMJ Publishing Group Ltd and European League Against Rheumatism, 2017. http://dx.doi.org/10.1136/annrheumdis-2017-eular.3629.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Chandrasekaran, Ramya, Darbie Whitman, Ray Fox, Tom Graddis, and Kamal Puri. "39 Interrogating elite responder humoral responses to identify novel targets and therapeutic antibodies for the treatment of cancer." In SITC 37th Annual Meeting (SITC 2022) Abstracts. BMJ Publishing Group Ltd, 2022. http://dx.doi.org/10.1136/jitc-2022-sitc2022.0039.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Yoshii, I. "AB0997 Clinical characteristics of non-responder to denosumab treatment for postmenopausal osteoporosis in japanese woman." In Annual European Congress of Rheumatology, EULAR 2018, Amsterdam, 13–16 June 2018. BMJ Publishing Group Ltd and European League Against Rheumatism, 2018. http://dx.doi.org/10.1136/annrheumdis-2018-eular.1263.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Signorelli, Diego, Michele Del Vecchio, Marina Garassino, et al. "Abstract A018: Onset of dysthyroidism during treatment with immune checkpoint inhibitors is increased in responder patients." In Abstracts: CRI-CIMT-EATI-AACR Inaugural International Cancer Immunotherapy Conference: Translating Science into Survival; September 16-19, 2015; New York, NY. American Association for Cancer Research, 2016. http://dx.doi.org/10.1158/2326-6074.cricimteatiaacr15-a018.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Ashina, Messoud, Richard B. Lipton, Jessica Ailani, et al. "Responder Rates With Eptinezumab Over 24 Weeks in Patients With Prior Migraine Preventive Treatment Failures (S47.007)." In 2023 Annual Meeting Abstracts. Lippincott Williams & Wilkins, 2023. http://dx.doi.org/10.1212/wnl.0000000000203094.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Treatment responder"

1

Yu, Winifred, Elise Digga, Courtney Luterbach, et al. Association Between Outcomes and Dental Services in People Receiving Treatments That Cause Medication-Related Osteonecrosis of the Jaw: A Rapid Response Review. AHRQ, 2025. https://doi.org/10.23970/ahrqepc_rapid_dental_jaw.

Full text
Abstract:
This review is undertaken to answer the following questions: Key Question 1: What is the effectiveness of dental services in improving health outcomes in people receiving treatments that cause medication-related osteonecrosis of the jaw (MRONJ) before, during, or after treatment with bisphosphonates, antiangiogenics, and other drugs for conditions other than cancer? Key Question 2: What are the clinical practice guidelines or standards for dental care for people receiving treatments that cause MRONJ? Key Messages: The body of evidence informing KQ1 consists of two randomized clinical trials (R
APA, Harvard, Vancouver, ISO, and other styles
2

Bray, Elizabeth, Zvi Lerner, and Alexander Poljakoff-Mayber. The Role of Phytohormones in the Response of Plants to Salinity Stress. United States Department of Agriculture, 1994. http://dx.doi.org/10.32747/1994.7613007.bard.

Full text
Abstract:
Salinity is an increasing problem in many irrigated areas of crop production and is a significant factor in reducing crop productivity. Developmental, physiological, and molecular responses to salinity were studied in order to improve our understanding of these responses. Improvements in our understanding of plant responses to salinity are necessary in order to develop crops with improved salt tolerance. Previously, in Israel, it was shown that Sorghum biccolor can adapt to an otherwise lethal concentration of NaCl. These experiments were refined and it was shown that there is a specific windo
APA, Harvard, Vancouver, ISO, and other styles
3

Schad, Aaron, Gary Dick, Kris Erickson, Paul Fuhrmann, and Lynde Dodd. Vegetation community changes in response to phragmites management at Times Beach, Buffalo, New York. Engineer Research and Development Center (U.S.), 2021. http://dx.doi.org/10.21079/11681/42149.

Full text
Abstract:
Management of invasive phragmites (Phragmites australis [Cav.] Trin. Ex Steud.) in the United States has proven challenging over the last several decades. Various methods for control exist, but integrated approaches appear to have the most success. However, documentation of vegetation community–wide responses to these approaches remains limited. This study monitored plant community changes at Times Beach, New York, over a five-year period. In concert with mowing and thatch removal in all areas, the study evaluated two herbicides separately and together, representing three experimental treatmen
APA, Harvard, Vancouver, ISO, and other styles
4

Manski, Charles. Using Studies of Treatment Response to Inform Treatment Choice in Heterogeneous Populations. National Bureau of Economic Research, 2000. http://dx.doi.org/10.3386/t0263.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Angrist, Joshua, and Guido Imbens. Average Causal Response with Variable Treatment Intensity. National Bureau of Economic Research, 1995. http://dx.doi.org/10.3386/t0127.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Manski, Charles F. Identification of treatment response with social interactions. Institute for Fiscal Studies, 2010. http://dx.doi.org/10.1920/wp.cem.2010.0110.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Pokrzywinski, Kaytee, West Bishop, Christopher Grasso, Kaitlin Volk, and Kurt Getsinger. Chemical management strategies for starry stonewort : a mesocosm study. Engineer Research and Development Center (U.S.), 2021. http://dx.doi.org/10.21079/11681/42040.

Full text
Abstract:
US Environmental Protection Agency (USEPA) approved algaecides and herbicides are frequently utilized to manage nuisance algae and aquatic macrophytes. However, there is limited information available on the effectiveness of these products for the management of starry stonewort. Thus, the goal of this research was to discern effective chemical control products for later growth stages of starry stonewort using mesocosm studies. Eleven treatments were evaluated using various combinations of four copper-based products, endothall, diquat, and carfentrazone – all with USEPA registrations for use in
APA, Harvard, Vancouver, ISO, and other styles
8

DeJong, Joel L., and David Haden. Soybean Yield Response to Late Soybean Aphid Treatment. Iowa State University, Digital Repository, 2004. http://dx.doi.org/10.31274/farmprogressreports-180814-661.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Patricia van Es, Nina. Illness and the Treatment Response: The Patient's View. Portland State University Library, 2000. http://dx.doi.org/10.15760/etd.6762.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Sartain, Bradley, Erika Haug, Kurt Getsinger, Benjamin Sperry, Mark Heilman, and Mike Greer. Small plot applications of florpyrauxifen–benzyl (Procellacor SC™) for control of monoecious hydrilla in Roanoke Rapids Lake, NC. Engineer Research and Development Center (U.S.), 2023. http://dx.doi.org/10.21079/11681/47115.

Full text
Abstract:
Four demonstration plots were selected at Roanoke Rapids Lake, NC to evaluate water exchange and aqueous herbicide residues in stands of submersed aquatic vegetation (SAV) following treatment with rhodamine wt dye and florpyrauxifen-benzyl to control monecious hydrilla. Florpyrauxifen-benzyl (Procellacor™ SC) was applied in combination with Rhodamine WT (RWT) at two of the plots. Dye measurements and herbicide residue samples were collected at specific time intervals to draw comparisons between herbicide and RWT dye dissipation. The two additional plots served as reference plots to the treatme
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Treatment responder' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography